Investor Relations

Stock price graph
     

ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. The Company’s first commercial product, the CoolSculpting® System, selectively reduces stubborn fat bulges that may not respond to diet or exercise. CoolSculpting is clinically proven to reduce fat bulges in a 60-minute procedure, allowing patients to achieve noticeable and measurable aesthetic results. ZELTIQ has received regulatory clearance from the U.S. Food and Drug Administration to market CoolSculpting in the United States for the selective reduction of fat around the flanks. ZELTIQ has also received regulatory approval or is otherwise free to market CoolSculpting in 46 international markets.




Shareholder Tools

shareholder briefcase investor kit email alerts download library news feeds contact us Share this page

Shareholder Briefcase
Collect, save and zip multiple files for fast download and email, or bookmark your favorite files for a later visit to the IR website.

Printed Materials
Order printed documents to be sent to you by mail, or view a history of the documents you have previously requested.

Email Alerts
Fine-tune the emails you receive from ZELTIQ with specific SEC filing types, news types, and stock price changes. Choose to receive the closing stock price each day, or a summary of stock prices at the end of the week.

Download Library
Find exactly the file(s) you need. Send files directly into your Shareholder Briefcase, or download individual files.

Snapshot
Download a synopsis of the most recent content within our IR website.

RSS Feeds
Subscribe to RSS news feeds to automatically be notified of SEC filings and news releases.

Contact Us
Contact our Investor Relations department.

Email this page
Email this page to yourself or a friend.

Print this page
Print a copy of this page for your records.

Search Investor Relations
Use the form below to search the investor relations site.

Share this page
Share this page with your friends using your favorite social networking site.